Enhancing Rwanda National Cancer Registry leveraging on information technology and strengthening breast cancer care coordination system.

Funded by Pfizer, in close collaboration with the Rwanda Biomedical Center (RBC), The project has two main objectives: (1) To reduce breast cancer mortality in Rwanda by improving access to early detection services and linkage to diagnostic and treatment services through a digitally enabled patient navigation system, (2) To enhance the national cancer registry leveraging on information technology providing accurate information on cancer incidence and mortality in Rwanda.